SARS-CoV-2 Immunohistochemistry In Placenta

Int J Surg Pathol. 2022 Jun;30(4):393-396. doi: 10.1177/10668969211067754. Epub 2021 Dec 23.

Abstract

Compared to the parental SARS-CoV-2 virus, infections by the now dominant Delta variant of SARS-CoV-2 appear to be more common and more severe in pregnant women. The need for a robust, cheap, and quick method for diagnosing placental infection by SARS-CoV-2 has thus become more acute. Here, we describe a highly sensitive and specific immunohistochemical assay for SARS-CoV-2 nucleocapsid protein for routine use in placental pathology practice.

Keywords: COVID-19; SARS-CoV-2; electron microscopy; immunohistochemistry; nucleocapsid protein; placenta; spike protein; ultrastructure.

MeSH terms

  • COVID-19* / diagnosis
  • Female
  • Humans
  • Immunohistochemistry
  • Placenta / pathology
  • Pregnancy
  • Pregnancy Complications, Infectious* / diagnosis
  • Pregnancy Complications, Infectious* / pathology
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus / metabolism

Substances

  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2

Supplementary concepts

  • SARS-CoV-2 variants